Mainstream Capital Management »

iShares NASDAQ Biotechnology Index shares owned by Mainstream Capital Management

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Mainstream Capital Management from 13F filings

Historical chart of Mainstream Capital Management investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Mainstream Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Mainstream Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $205k 1.1k 190.19
2024-12-31 $150k 1.1k 132.21

More positions owned by Mainstream Capital Management

Jpmorgan Ultra-short Income Etf Etf (JPST)
Apple Stock (AAPL)
Goldman Sachs Ultra Short Bond Etf Etf (GSST)
Amazon Stock (AMZN)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Nvidia Corporation Stock (NVDA)
Ishares Russell 1000 Growth Etf Etf (IWF)
Meta Platforms Inc Cl A Stock (META)
Corning Stock (GLW)
Ishares Russell 1000 Value Etf Etf (IWD)
Ishares Core S&p 500 Etf Etf (IVV)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Eli Lilly & Co Stock (LLY)

View all positions for Mainstream Capital Management

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Citigroup
Morgan Stanley
Bnp Paribas Arbitrage, Snc
Two Sigma Investments
Goldman Sachs Group
Envestnet Asset Management
Raymond James Financial
Wells Fargo & Company
Commerce Bank N A
UBS Group
Peak6
Susquehanna International
LPL Financial
Royal Bank of Canada

View all funds holding iShares NASDAQ Biotechnology Index